6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Original text

Rate this translation

Your feedback will be used to help improve Google Translate

Latest Press Releases

Time	Headline
Just now	Appendix 4C and Quarterly Activities Report - March 2026
Just now	Lazard to Acquire Campbell Lutyens, Creating the Global Leader in Private Capital Advisory
9m ago	Haier Biomedical Drives Global Leap of Life Science Infrastructure: International Business Hits Record High for 36% of Annual Revenue in 2025
11m ago	Correction to Austral Gold Q1 2026 Quarterly Activities Report
11m ago	Austral Gold Files Q1 2026 Quarterly Activities Report

About

Sarepta Therapeutics Inc (NASDAQ:SRPT) — investor relations, events, news, and company updates on 6ix.

Latest News

Sarepta Therapeutics to Announce First Quarter 2026 Financial Results

Sarepta Announces First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1

Sarepta to Share First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1

Sarepta Provides Regulatory Update on AMONDYS 45® and VYONDYS 53®

Sarepta Announces that Screening and Enrollment are Underway in ENDEAVOR Cohort 8 to Evaluate Enhanced Immunosuppression Regimen as Part of ELEVIDYS Gene Therapy for Non-Ambulant Individuals with Duchenne

Financials

Revenue

$2.2 B

Market Cap

$2.44 B

EPS

-7.13

Community Chat

Ask AI